Literature DB >> 24268853

Is there risk of stroke with aflibercept?

Paul E Beaumont1, Peter Petocz2, Hyong K Kang1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24268853     DOI： 10.1016/j.ophtha.2013.09.020

Source DB:  PubMed          Journal:  Ophthalmology        ISSN： 0161-6420            Impact factor:   12.079


× No keyword cloud information.
  3 in total

1.  A pharmacoepidemiologic study of ranibizumab and aflibercept use 2013-2016. The Fight Retinal Blindness! Project.

Authors:  Daniel Barthelmes; Vuong Nguyen; Richard Walton; Mark C Gillies; Vincent Daien
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-07-27       Impact factor: 3.117

2.  Hypertension and Ischemic Stroke After Aflibercept for Retinopathy of Prematurity.

Authors:  Fatemeh Bazvand; Elias Khalili Pour; Golnaz Gharehbaghi; Hooshang Faghihi; Alireza Khodabandeh; Mohammadreza Mehrabi Bahar; Hamid Riazi-Esfahani
Journal:  Int Med Case Rep J       Date:  2020-07-03

3.  Neovascular Age-Related Macular Degeneration in the Very Old (≥90 Years): Epidemiology, Adherence to Treatment, and Comparison of Efficacy.

Authors:  Yousif Subhi; Torben Lykke Sørensen
Journal:  J Ophthalmol       Date:  2017-06-04       Impact factor: 1.909
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.